License and Supply Agreement, dated November 30, 2010, by and between Melinta Therapeutics, Inc. and Cydex Pharmaceuticals, Inc. (a wholly owned subsidiary of Ligand Pharmaceuticals Incorporated), incorporated by reference to Exhibit 10.29 of the S-1/A filed by Rib-X Pharmaceuticals, Inc. on March 13, 2012 from MELINTA …

Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (amf) 6. Oct 30, 2019. SUMMONS Returned Executed by CyDex Pharmaceuticals, Inc.. Lupin Pharmaceuticals, Inc. served on 10/30/2019, answer due 11/20/2019.

ACROTECH BIOPHARMA LLC and CyDex Pharmaceuticals, Inc. Defendant: ALEMBIC PHARMACEUTICALS, LTD, ALEMBIC GLOBAL HOLDING SA and ALEMBIC PHARMACEUTICALS, INC. Case Number: 2:2020cv19295: Filed: December 15, 2020: Court: US District Court for the District of New Jersey: Nature of Suit: Patent - …

1.4 "CyDex" means CyDex, Inc. and any subsidiary or any other entity in which CyDex, Inc., directly or indirectly, owns more than 50% of the voting securities, partnership, or other ownership interest. 1.5 "Confidential Information" shall mean any proprietary, confidential information (whether or not patentable or copyrightable), whether or not so marked, that …

SUPPLY AGREEMENT . THIS SUPPLY AGREEMENT (this "Agreement") is made this 28th day of September, 2012 (the "Effective Date") between: . CYDEX PHARMACEUTICALS, INC., a Delaware corporation, with offices at 11119 North Torrey Pines Road, Suite 200, La Jolla, California 92037) ("CyDex"); and . MEI PHARMA, INC., …

CyDEx is the only hands-on national exercise with a high level of intricacy and realism. Complex simulations took place this year in a cyber security test site, especially created and customized by SRI specialists. This year edition was held exclusively online for the first time - planning conferences and exercise likewise.

Ligand 's CyDex had claimed that Lupin 's proposed generic version of Evomela infringes two patents for the cancer treatment.. Lupin won't sell its copycat "until such date permitted by the settlement agreement," according to proposed consent judgment and dismissal order filed Monday but not yet approved in federal court in Wilmington, …

Ganaxolone (ZTALMY®; Marinus Pharmaceuticals) is a synthetic neuroactive steroid that acts as a positive allosteric modulator of the gamma-aminobutyric acid (GABA)A receptor complex. Ganaxolone received its first approval in March 2022 in the USA for the treatment of seizures associated with cyclin-dependent kinase-like 5 …

He joined CyDex in 2005. Dr. Antle is currently responsible for quality assurance, internal drug product quality, operations, distribution and logistics for Captisol. From 1999 to 2005, Dr. Antle was Technical …

Ligand Pharmaceuticals' CyDex Unit and Lupin have settled a patent lawsuit over CyDex's cancer drug Evomela. Lupin won't sell a generic version of the drug until …

For each respective year from 2011 through 2016, 20% of all CyDex-related revenue, but only to the extent that and beginning only when CyDex-related revenue for such year exceed $15,000,000; plus an additional 10% of all CyDex-related revenue recognized during such year, but only to the extent that and beginning only when aggregate CyDex-related …

LENEXA, Kan., Dec. 14 /PRNewswire/ -- CyDex, Inc., a specialty pharmaceutical company developing improved products through innovative drug delivery, today announced ABILIFY® Injection, a new intramuscular form of the antipsychotic medication ABILIFY® (aripiprazole) from Bristol-Myers Squibb Company and Otsuka …

MANILA, Philippines — The Armed Forces of the Philippines kicked off on Monday its weeklong exercise on cyber defense (Cydex), adopting cyberspace as the fourth domain of military operations for

On 05/23/2019 CyDex Pharmaceuticals, Inc filed an Intellectual Property - Patent court case against Alembic Global Holding SA in U.S. District Courts. Court records for this case are available from Delaware District.

(A)CYDEX agrees to sell Product to Gilead and its Affiliates based on orders placed under this Agreement pursuant to a Purchase Order (as defined below).In addition, CYDEX agrees to sell Product to Gilead's Affiliates based on orders placed under this Agreement pursuant to a Purchase Order (as defined below); provided, that Gilead shall be jointly and …

CYDEX PHARMACEUTICALS, INC., a Delaware corporation, with offices at 11119 North Torrey Pines Road, Suite 200, La Jolla, California 92037 ("CyDex"); and CURX PHARMACEUTICALS, INC., a Delaware corporation, with offices at 3210 Merryfield Row, San Diego, CA 92121 (" Company ").

For the purposes of this Agreement, the following definitions shall apply: "Captisol"means sulfobutylether ß(beta) cyclodextrin, sodium salt.CyDex supplies a uniquely modified form of such material under the Captisol ® brand, manufactured in accordance with the Specifications. For avoidance of doubt: the uniquely modified form of such material …

Cyblex MV 80.3 Tablet belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes. Cyblex MV 80.3 Tablet should be taken with food. Take it regularly at the same time each day to get the most …

Description. Developer of drug delivery technology based in San Diego, California. The company utilizes four Captisol-enabled products commercialized by Pfizer …

5. Dec 20, 2017. Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Ligand Pharmaceuticals, Inc. for CyDex Pharmaceuticals, Inc. filed by CyDex Pharmaceuticals, Inc. (ceg) (Entered: 12/21/2017) Main Doc ­ument.

Ligand Pharmaceuticals' (NASDAQ: LGND) CyDex Unit and Lupin have settled a patent lawsuit over CyDex's cancer drug Evomela. Lupin won't sell a generic version of the drug until a date agreed upon ...

CYDEX - Business Information. Law Firms & Legal Services · California, United States · <25 Employees. Since 1979, CYDEX Corporation has offered its clients exceptional software and systems engineering expertise culled from a broad spectrum of experience in industries as diverse as publishing, transportation, telecommunications, health care, manufacturing, …

CyDex compounds) and more than 400 pharmaceutical and biotechnology companies are using the technology in the development of their compounds, for delivery via various routes. At the same time, CyDex is progressing toward a specialty pharma model, with multiple Captisol-enabled drug products under development in-house. PFIZER'S CRUCIAL …

CyDex is developing its own pipeline of products using its enabling technology solutions, and partnering with pharmaceutical, specialty pharmaceutical and biotechnology companies. Private/Public: private Phone: (913)-685-8850 Fax: (913)-685-8856 Email: [email protected] Address: 10513 W. 84th Terrace Lenexa, KS 66214, United States of America

Exhibit 10.30. AMENDMENT TO LICENSE AGREEMENT . This Amendment to License Agreement (this "Amendment") is made and entered into as of February 8, 2019, by and among Ligand Pharmaceuticals Incorporated, a Delaware corporation ("Ligand"), Neurogen Corporation, a Delaware corporation ("Neurogen"), CyDex Pharmaceuticals, Inc., a …

CYDEX shall not be obligated to purchase FORECASTED quantities of CAPTISOL if CYDEX has entered into a contract to purchase CAPTISOL from an ALTERNATE SUPPLIER. 10.2 Governing Law. This AGREEMENT shall be construed in accordance with the laws of the State of Delaware in the United States of America, without giving effect to …

(Filing fee $ 400, receipt number 0311-2766092) - filed by CyDex Pharmaceuticals, Inc. (Attachments: #1 Exhibits A-B, #2 Civil Cover Sheet)(amf) October 29, 2019: Summons Issued with Magistrate Consent Notice attached as to Lupin Limited and Lupin Pharmaceuticals, Inc. on 10/29/2019. Requesting party or attorney should pick up …

CyDex agrees that CyDex shall produce (or have produced for it as set forth in Section 2.3), sell, supply and deliver to Company and the other Permitted Purchasers of the Permitted Purchaser Requirements during the Term, subject to the provisions of this Agreement. CyDex shall only be required to sell the Permitted Purchaser Requirements ...

NEW HAVEN, Conn., Aug. 12, 2014 (GLOBE NEWSWIRE) - Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the …

To develop allopregnanolone as a therapeutic for Alzheimer's disease, we investigated multiple formulations and routes of administration in translationally relevant animal models of both sexes. Subcutaneous, …